Euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus 3 days after initiating sodium‐glucose cotransporter 2 inhibitor while on an extremely low carbohydrate diet: A case report

This paper presents a case with type 2 diabetes mellitus on a very‐low‐carbohydrate diet who developed euglycemic diabetic ketoacidosis (EDKA) 3 days after starting sodium‐glucose cotransporter 2 inhibitors (SGLT2i). When initiating SGLT2i, healthcare providers should confirm the implementation of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Ayumi, Katayama, Akihiro, Sue, Mihiro, Hasegawa, Momoka, Maeda, Megumi, Matoba, Masaki, Ishii, Takahiro, Kuribayashi, Remi, Tenta, Masafumi, Matsushita, Yuichi, Takeda, Masaya, Iseda, Izumi, Wakatsuki, Toshiyuki, Hida, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666914/
https://www.ncbi.nlm.nih.gov/pubmed/36408091
http://dx.doi.org/10.1002/ccr3.6572
Descripción
Sumario:This paper presents a case with type 2 diabetes mellitus on a very‐low‐carbohydrate diet who developed euglycemic diabetic ketoacidosis (EDKA) 3 days after starting sodium‐glucose cotransporter 2 inhibitors (SGLT2i). When initiating SGLT2i, healthcare providers should confirm the implementation of a low‐carbohydrate diet and provide intensive guidance to prevent EDKA.

Ejemplares similares